Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients With Persistent Generalized Lymphadenopathy
Clinical trial NCT00000728 · COMPLETED
Trial details
- NCT number
- NCT00000728
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.